Covered recipient · General Payments record
KIMBERLY ANN PERTTU
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,745.85
- Reported across 99 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $458.33 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $112.48 | 6 |
| Astellas Pharma US Inc | $53.34 | 3 |
| ABBVIE INC. | $50.36 | 3 |
| Lundbeck LLC | $41.14 | 2 |
| Xeris Pharmaceuticals, Inc. | $39.88 | 2 |
| Lilly USA, LLC | $37.12 | 2 |
| Novo Nordisk AS | $31.84 | 2 |
| Janssen Pharmaceuticals, Inc | $28.82 | 2 |
| Amgen Inc. | $22.17 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.97 | 1 |
| Merck Sharp & Dohme Corporation | $20.21 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.18 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105245326 | CMS |
| ABBVIE INC. | $18.51 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105245330 | CMS |
| ABBVIE INC. | $17.67 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105245334 | CMS |
| Amgen Inc. | $22.17 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111675462 | CMS |
| Astellas Pharma US Inc | $18.19 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139339134 | CMS |
| Astellas Pharma US Inc | $16.95 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139370799 | CMS |
| Astellas Pharma US Inc | $18.20 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139375001 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.97 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118131431 | CMS |
| Janssen Pharmaceuticals, Inc | $14.12 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078247691 | CMS |
| Janssen Pharmaceuticals, Inc | $14.70 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078247693 | CMS |
| Lilly USA, LLC | $17.01 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135133430 | CMS |
| Lilly USA, LLC | $20.11 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135136694 | CMS |
| Lundbeck LLC | $16.96 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145955945 | CMS |
| Lundbeck LLC | $24.18 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145955947 | CMS |
| Merck Sharp & Dohme LLC | $20.21 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141963657 | CMS |
| Novo Nordisk Inc | $15.81 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096617826 | CMS |
| Novo Nordisk Inc | $16.03 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096934703 | CMS |
| PFIZER INC. | $17.68 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131168692 | CMS |
| PFIZER INC. | $15.70 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131177590 | CMS |
| PFIZER INC. | $20.09 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131203845 | CMS |
| PFIZER INC. | $20.09 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131214510 | CMS |
| PFIZER INC. | $19.43 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131378756 | CMS |
| PFIZER INC. | $19.49 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131786696 | CMS |
| Xeris Pharmaceuticals, Inc. | $18.46 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144601829 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.42 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144601831 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.